Skip to main content

12-11-2019 | Psoriatic arthritis | Video | Article

Expert commentary: The DISCOVER trials

Oliver FitzGerald comments on the findings from the DISCOVER-1 and DISCOVER-2 trials, which demonstrated the efficacy of guselkumab for the treatment of psoriatic arthritis (3:36).


Back to the ACR/ARP 2019 conference hub

Related topics

Telemedicine in rheumatology: COVID-19 and beyond

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Image Credits